Published in J Virol on August 01, 2000
Compartmentalization of hepatitis C virus genotypes between plasma and peripheral blood mononuclear cells. J Virol (2005) 1.41
Negative-strand hepatitis C virus (HCV) RNA in peripheral blood mononuclear cells from anti-HCV-positive/HIV-infected women. J Infect Dis (2006) 1.17
Mutation Master: profiles of substitutions in hepatitis C virus RNA of the core, alternate reading frame, and NS2 coding regions. RNA (2002) 1.13
Antiviral activities of ISG20 in positive-strand RNA virus infections. Virology (2010) 1.08
Human cell types important for hepatitis C virus replication in vivo and in vitro: old assertions and current evidence. Virol J (2011) 0.97
Analysis of in vitro replicated human hepatitis C virus (HCV) for the determination of genotypes and quasispecies. Virol J (2006) 0.83
Evidence of distinct populations of hepatitis C virus in the liver and plasma of patients co-infected with HIV and HCV. J Med Virol (2014) 0.78
Analysis of a non-structural gene reveals evidence of possible hepatitis C virus (HCV) compartmentalization. J Med Virol (2012) 0.77
Evolution of naturally occurring 5'non-coding region variants of Hepatitis C virus in human populations of the South American region. Virol J (2007) 0.77
Novel nucleotide and amino acid covariation between the 5'UTR and the NS2/NS3 proteins of hepatitis C virus: bioinformatic and functional analyses. PLoS One (2011) 0.76
Hepatitis C virus has a genetically determined lymphotropism through co-receptor B7.2. Nat Commun (2017) 0.75
Internal ribosome entry site within hepatitis C virus RNA. J Virol (1992) 9.14
A prokaryotic-like mode of cytoplasmic eukaryotic ribosome binding to the initiation codon during internal translation initiation of hepatitis C and classical swine fever virus RNAs. Genes Dev (1998) 7.72
Evidence for in vitro replication of hepatitis C virus genome in a human T-cell line. Proc Natl Acad Sci U S A (1992) 3.55
A phylogenetically conserved stem-loop structure at the 5' border of the internal ribosome entry site of hepatitis C virus is required for cap-independent viral translation. J Virol (1999) 3.13
An infectious molecular clone of a Japanese genotype 1b hepatitis C virus. Hepatology (1999) 3.00
Differences in replication of attenuated and neurovirulent polioviruses in human neuroblastoma cell line SH-SY5Y. J Virol (1989) 2.46
The La antigen binds 5' noncoding region of the hepatitis C virus RNA in the context of the initiator AUG codon and stimulates internal ribosome entry site-mediated translation. Proc Natl Acad Sci U S A (1997) 2.43
Cell cycle regulation of hepatitis C virus internal ribosomal entry site-directed translation. Gastroenterology (2000) 2.05
Heterogeneous nuclear ribonucleoprotein L interacts with the 3' border of the internal ribosomal entry site of hepatitis C virus. J Virol (1998) 2.00
The molecular virology of hepatitis C. Hepatology (1997) 2.00
In vivo tropism of hepatitis C virus genomic sequences in hematopoietic cells: influence of viral load, viral genotype, and cell phenotype. Blood (1998) 1.98
Specific detection of hepatitis C virus minus strand RNA in hematopoietic cells. J Clin Invest (1996) 1.79
Internal ribosome entry site-mediated translation in hepatitis C virus replication. Curr Top Microbiol Immunol (2000) 1.78
Correlation between the infectivity of hepatitis C virus in vivo and its infectivity in vitro. Proc Natl Acad Sci U S A (1993) 1.78
Mutations within the 5' nontranslated region of hepatitis A virus RNA which enhance replication in BS-C-1 cells. J Virol (1992) 1.73
Susceptibility of human T-lymphotropic virus type I infected cell line MT-2 to hepatitis C virus infection. Biochem Biophys Res Commun (1995) 1.54
Transient expression of cellular polypyrimidine-tract binding protein stimulates cap-independent translation directed by both picornaviral and flaviviral internal ribosome entry sites In vivo. Mol Cell Biol (2000) 1.47
Specific interaction of glyceraldehyde 3-phosphate dehydrogenase with the 5'-nontranslated RNA of hepatitis A virus. J Biol Chem (1996) 1.40
Mutations within the 5' nontranslated RNA of cell culture-adapted hepatitis A virus which enhance cap-independent translation in cultured African green monkey kidney cells. J Virol (1996) 1.34
Genetic diversity and tissue compartmentalization of the hepatitis C virus genome in blood mononuclear cells, liver, and serum from chronic hepatitis C patients. J Virol (1998) 1.31
Hepatitis C virus quasispecies in patients infected with HIV-1: correlation with extrahepatic viral replication. Virology (1998) 1.27
Attenuation stem-loop lesions in the 5' noncoding region of poliovirus RNA: neuronal cell-specific translation defects. J Virol (1996) 1.26
Hepatitis C virus RNA in peripheral blood mononuclear cells: comparing acute and chronic hepatitis C virus infection. Hepatology (1996) 1.24
Characterization of long-term cultures of hepatitis C virus. J Virol (1996) 1.18
Sequence analysis of the hepatitis C virus genome recovered from serum, liver, and peripheral blood mononuclear cells of infected chimpanzees. J Virol (1997) 1.17
Infection of a chimpanzee with hepatitis C virus grown in cell culture. J Gen Virol (1998) 1.13
Differences in hepatitis C virus quasispecies composition between liver, peripheral blood mononuclear cells and plasma. J Gen Virol (1997) 1.08
In vitro replication of hepatitis C virus in a human lymphoid cell line (H9) J Hepatol (1994) 0.92
Multicycle infection of hepatitis C virus in cell culture and inhibition by alpha and beta interferons. J Virol (1994) 0.89
Hepatitis A virus translation is rate-limiting for virus replication in MRC-5 cells. Virology (1999) 0.84
Secondary structure of the 5' nontranslated regions of hepatitis C virus and pestivirus genomic RNAs. Nucleic Acids Res (1992) 4.58
Equilibrium centrifugation studies of hepatitis C virus: evidence for circulating immune complexes. J Virol (1993) 4.13
Radioimmunofocus assay for quantitation of hepatitis A virus in cell cultures. J Clin Microbiol (1983) 3.20
Stability of a stem-loop involving the initiator AUG controls the efficiency of internal initiation of translation on hepatitis C virus RNA. RNA (1996) 3.14
Structural requirements for initiation of translation by internal ribosome entry within genome-length hepatitis C virus RNA. Virology (1996) 3.14
A phylogenetically conserved stem-loop structure at the 5' border of the internal ribosome entry site of hepatitis C virus is required for cap-independent viral translation. J Virol (1999) 3.13
An infectious molecular clone of a Japanese genotype 1b hepatitis C virus. Hepatology (1999) 3.00
Type A viral hepatitis. New developments in an old disease. N Engl J Med (1985) 2.86
The 5' nontranslated region of hepatitis A virus RNA: secondary structure and elements required for translation in vitro. J Virol (1991) 2.83
Non-A, non-B hepatitis: ultrastructural evidence for two agents in experimentally infected chimpanzees. Science (1979) 2.78
The rhinovirus type 14 genome contains an internally located RNA structure that is required for viral replication. RNA (1998) 2.61
Molecular epidemiology of human hepatitis A virus defined by an antigen-capture polymerase chain reaction method. Proc Natl Acad Sci U S A (1990) 2.52
Complete nucleotide sequence of a cell culture-adapted variant of hepatitis A virus: comparison with wild-type virus with restricted capacity for in vitro replication. Virology (1988) 2.51
Frequency of illness associated with epidemic hepatitis A virus infections in adults. Am J Epidemiol (1985) 2.20
Oocyst-transmitted toxoplasmosis associated with ingestion of contaminated water. N Engl J Med (1982) 2.07
Cell cycle regulation of hepatitis C virus internal ribosomal entry site-directed translation. Gastroenterology (2000) 2.05
Obesity as a predictor of poor antibody response to hepatitis B plasma vaccine. JAMA (1985) 2.03
Low efficiency of the 5' nontranslated region of hepatitis A virus RNA in directing cap-independent translation in permissive monkey kidney cells. J Virol (1994) 2.00
Transmission of hepatitis A virus among recently captured Panamanian owl monkeys. J Med Virol (1982) 1.94
Capsid coding sequence is required for efficient replication of human rhinovirus 14 RNA. J Virol (1996) 1.85
Specific immunoglobulin M response to hepatitis A virus determined by solid-phase radioimmunoassay. Infect Immun (1980) 1.79
Internal ribosome entry site-mediated translation in hepatitis C virus replication. Curr Top Microbiol Immunol (2000) 1.78
The influence of downstream protein-coding sequence on internal ribosome entry on hepatitis C virus and other flavivirus RNAs. RNA (2001) 1.77
Long-term acyclovir suppression of frequently recurring genital herpes simplex virus infection. A multicenter double-blind trial. JAMA (1988) 1.76
Mutations within the 5' nontranslated region of hepatitis A virus RNA which enhance replication in BS-C-1 cells. J Virol (1992) 1.73
A second site for Epstein-Barr virus shedding: the uterine cervix. Lancet (1986) 1.61
Replication of EBV in epithelial cells during infectious mononucleosis. Nature (1977) 1.61
Primary isolation and serial passage of hepatitis A virus strains in primate cell cultures. J Clin Microbiol (1984) 1.61
Self-assembly of nucleocapsid-like particles from recombinant hepatitis C virus core protein. J Virol (2001) 1.59
Horizontal transmission of hepatitis B virus. Lancet (1989) 1.57
Antigenic structure of human hepatitis A virus defined by analysis of escape mutants selected against murine monoclonal antibodies. J Virol (1992) 1.56
Virus-specific mechanisms of carcinogenesis in hepatitis C virus associated liver cancer. Oncogene (2011) 1.56
Artificial assembly of envelope particles of HVJ (Sendai virus). I. Assembly of hemolytic and fusion factors from envelopes solubilized by Nonidet P40. Virology (1972) 1.53
Gut microbes define liver cancer risk in mice exposed to chemical and viral transgenic hepatocarcinogens. Gut (2010) 1.47
Transient expression of cellular polypyrimidine-tract binding protein stimulates cap-independent translation directed by both picornaviral and flaviviral internal ribosome entry sites In vivo. Mol Cell Biol (2000) 1.47
Translation initiation in GB viruses A and C: evidence for internal ribosome entry and implications for genome organization. J Virol (1996) 1.46
Risk factors for horizontal transmission of hepatitis B virus in a rural district in Ghana. Am J Epidemiol (1998) 1.44
Specific interaction of glyceraldehyde 3-phosphate dehydrogenase with the 5'-nontranslated RNA of hepatitis A virus. J Biol Chem (1996) 1.40
On the study of Sendai virus hemolysis. I. Complete Sendai virus lacking in hemolytic activity. Virology (1976) 1.40
Cell type-specific proteins which interact with the 5' nontranslated region of hepatitis A virus RNA. J Virol (1993) 1.40
Isolation and characterization of two distinct types of HVJ (Sendai virus) spikes. Virology (1974) 1.36
Combined immunoaffinity cDNA-RNA hybridization assay for detection of hepatitis A virus in clinical specimens. J Clin Microbiol (1985) 1.35
Mutations within the 5' nontranslated RNA of cell culture-adapted hepatitis A virus which enhance cap-independent translation in cultured African green monkey kidney cells. J Virol (1996) 1.34
Production of antibody associated with non-A, non-B hepatitis in a chimpanzee lymphoblastoid cell line established by in vitro transformation with Epstein-Barr virus. Proc Natl Acad Sci U S A (1985) 1.32
Antigenic relatedness of two strains of hepatitis A virus determined by cross-neutralization. Infect Immun (1983) 1.29
Mutational analysis of the GB virus B internal ribosome entry site. J Virol (2000) 1.29
Seroepidemiological survey of hepatitis B and C virus infections in Ghanaian children. J Med Virol (1996) 1.29
A military community outbreak of hepatitis type A related to transmission in a child care facility. Am J Epidemiol (1980) 1.27
Experimental infection of the New World owl monkey (Aotus trivirgatus) with hepatitis A virus. Infect Immun (1983) 1.27
Immunogenic domains of hepatitis delta virus antigen: peptide mapping of epitopes recognized by human and woodchuck antibodies. J Virol (1990) 1.25
An infectious cDNA clone of a cytopathic hepatitis A virus: genomic regions associated with rapid replication and cytopathic effect. Virology (1995) 1.24
Neutralizing antibody to hepatitis A virus in immune serum globulin and in the sera of human recipients of immune serum globulin. Gastroenterology (1985) 1.24
Core protein-coding sequence, but not core protein, modulates the efficiency of cap-independent translation directed by the internal ribosome entry site of hepatitis C virus. J Virol (2000) 1.22
Neutralization escape mutants define a dominant immunogenic neutralization site on hepatitis A virus. J Virol (1987) 1.22
Incomplete neutralization of hepatitis A virus in vitro due to lipid-associated virions. J Gen Virol (1985) 1.18
Identification of an immunodominant antigenic site involving the capsid protein VP3 of hepatitis A virus. Proc Natl Acad Sci U S A (1988) 1.18
Characterization of long-term cultures of hepatitis C virus. J Virol (1996) 1.18
Immunoblot analysis demonstrates that the large and small forms of hepatitis delta virus antigen have different C-terminal amino acid sequences. J Gen Virol (1992) 1.16
Detection of hepatitis A antigen in human liver. Infect Immun (1982) 1.15
Simultaneous infection with multiple herpesviruses. Am J Med (1979) 1.15
Serum neutralizing antibody response to hepatitis A virus. J Infect Dis (1983) 1.15
Structural basis of the oligomerization of hepatitis delta antigen. Structure (1998) 1.14
Recent advances in hepatitis A vaccine development. Virus Res (1990) 1.13
Prevention of endemic icteric viral hepatitis by administration of immune serum gamma globulin. J Infect Dis (1987) 1.12
Further studies by immunofluorescence of the monoclonal antibodies associated with experimental non-A, non-B hepatitis in chimpanzees and their relation to D hepatitis. Hepatology (1987) 1.11
Impaired immunogenicity of hepatitis B vaccine in obese persons. N Engl J Med (1986) 1.10
Virus-specific cofactor requirement and chimeric hepatitis C virus/GB virus B nonstructural protein 3. J Virol (2000) 1.10
Identification and site-directed mutagenesis of the primary (2A/2B) cleavage site of the hepatitis A virus polyprotein: functional impact on the infectivity of HAV RNA transcripts. Virology (1995) 1.09
Hepatitis A virus-specific immunoglobulin A mediates infection of hepatocytes with hepatitis A virus via the asialoglycoprotein receptor. J Virol (2000) 1.06
Quantitative analysis of hepatitis B virus DNA in saliva and semen of chronically infected homosexual men. J Infect Dis (1987) 1.05
Hepatitis delta virus mutant: effect on RNA editing. J Virol (1995) 1.05
Self-association of a synthetic peptide from the N terminus of the hepatitis delta virus protein into an immunoreactive alpha-helical multimer. Proc Natl Acad Sci U S A (1995) 1.05
Hepatitis delta virus antigen forms dimers and multimeric complexes in vivo. J Virol (1993) 1.05
Identification of new parvovirus DNA sequence in swine sera from Myanmar. Jpn J Infect Dis (2001) 1.04
Hepatitis C virus core protein induces apoptosis and impairs cell-cycle regulation in stably transformed Chinese hamster ovary cells. Hepatology (2000) 1.04
Characterization of a simian hepatitis A virus (HAV): antigenic and genetic comparison with human HAV. J Virol (1989) 1.02
GB virus C, hepatitis G virus, or human orphan flavivirus? Hepatology (1997) 1.02
Infectious hepatitis A virus particles produced in cell culture consist of three distinct types with different buoyant densities in CsCl. J Virol (1985) 1.01
On the study of Sendai virus hemolysis. II. Morphological study of envelop fusion and hemolysis. Virology (1976) 1.01
Infection of polarized cultures of human intestinal epithelial cells with hepatitis A virus: vectorial release of progeny virions through apical cellular membranes. J Virol (2000) 1.00
Solubilization of envelopes of HVJ (Sendai virus) with alkali-emasol treatment and reassembly of envelope particles with removal of the detergent. J Virol (1972) 0.99
Localization of hepatitis A antigen in liver tissue by peroxidase-conjugated antibody method: light and electron microscopic studies. J Immunol (1978) 0.99
The role of secretory immunity in hepatitis A virus infection. J Infect Dis (1991) 0.98
Failure to achieve predicted antibody responses with intradermal and intramuscular human diploid cell rabies vaccine. Lancet (1984) 0.97
Monoclonal antibodies to the hypervariable region 1 of hepatitis C virus capture virus and inhibit virus adsorption to susceptible cells in vitro. Virology (2000) 0.97
Attenuation phenotype of a cell culture-adapted variant of hepatitis A virus (HM175/p16) in susceptible New World owl monkeys. J Infect Dis (1993) 0.97
A simple method for clonal selection of hepatitis A virus based on recovery of virus from radioimmunofocus overlays. J Virol Methods (1985) 0.95
Hepatitis C virus core and envelope proteins do not suppress the host's ability to clear a hepatic viral infection. J Virol (2001) 0.94
Analysis of hepatitis A virus translation in a T7 polymerase-expressing cell line. Arch Virol Suppl (1994) 0.94
Preparation of a prototype inactivated hepatitis A virus vaccine from infected cell cultures. J Infect Dis (1986) 0.93
Genomic heterogeneity among human and nonhuman strains of hepatitis A virus. J Virol (1987) 0.93
IgM antibody to hepatitis B core antigen as a diagnostic parameter of acute infection with hepatitis B virus. J Infect Dis (1981) 0.93
Artificial assembly of envelope particles of HVJ (Sendai virus). II. Lipid components for formation of the active hemolysin. Virology (1972) 0.92
Maturation of the hepatitis A virus capsid protein VP1 is not dependent on processing by the 3Cpro proteinase. J Virol (1999) 0.92
Hepatic inflammation and immunity: a summary of a conference on the function of the immune system within the liver. Hepatology (2000) 0.92